Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1F | O60840 | 8/20 | 0.59 |
| ▸ | CACNA1D | Q01668 | 8/20 | 0.59 |
| ▸ | CACNA1S | Q13698 | 8/20 | 0.59 |
| ▸ | CACNA1C | Q13936 | 8/20 | 0.59 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | CCKBR | P32239 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.46 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6137186 | 0.88 | CACNA1F (0.57) | CACNA1FCACNA1DCACNA1SCACNA1CNR1I2 | |
| SCHEMBL6322062 | 0.87 | CACNA1F (0.54) | CACNA1FCACNA1DCACNA1SCACNA1CNR1I2 | |
| Methylamine SCHEMBL6859691 | 0.86 | CACNA1F (0.55) | CACNA1FCACNA1DCACNA1SCACNA1CNR1I2 | |
| SCHEMBL6318892 | 0.86 | CACNA1F (0.58) | CACNA1FCACNA1DCACNA1SCACNA1C | |
| SCHEMBL6312331 | 0.84 | CACNA1C (0.51) | CACNA1FCACNA1DCACNA1SCACNA1CNR1I2 | |
| SCHEMBL6312444 | 0.83 | CACNA1F (0.52) | CACNA1FCACNA1DCACNA1SCACNA1CNR1I2 | |
| SCHEMBL6314252 | 0.82 | CACNA1F (0.51) | CACNA1FCACNA1DCACNA1SCACNA1CNR1I2 | |
| SCHEMBL6314874 | 0.82 | CACNA1F (0.57) | CACNA1FCACNA1DCACNA1SCACNA1CADORA3 | |
| SCHEMBL6312447 | 0.81 | CACNA1F (0.55) | CACNA1FCACNA1DCACNA1SCACNA1CADORA3 | |
| SCHEMBL6139291 | 0.80 | CACNA1F (0.58) | CACNA1FCACNA1DCACNA1SCACNA1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6809102-B2 | FOR THERAPY OF PROLIFERATIVE DISEASES, SUCH AS CANCER; TO INTERRUPT MITOSIS | BRISTOL-MYERS SQUIBB COMPANY | 2004-10-26 | — | — | US | disclosed |